Business
Court rules that Mylan provided adequate public disclosures.
Hi, what are you looking for?
Jewish Business News
All posts tagged "Mylan Inc"
Business
6% workforce reduction, $2 billion in stock repurchases and vitamin unit sale in the offing
Mergers & Acquisitions
Teva will pay over $45 billion for the botox maker unit, report the "Wall Street Journal."
Business
Last week Teva CEO, Erez Vigodman said, “If the Mylan Pharmaceuticals shareholders support the acquisition of Perrigo, Teva will abandon its bid for Mylan.”
Business
Erez Vigodman: Size isn't everything; it's important to be better.
Business
Teva says it will seek ‘further appellate review’
Business
Teva is now close to the 4.6% stake in Mylan that will give it standing in the Netherlands courts.
Business
Mylan has confirmed it will dual list on the TASE and Nasdaq if it acquires Perrigo
Business
A Credit Suisse study finds that most hostile bids fail, especially if antitrust concerns are involved.
Business
Teva Chairman Yitzhak Peterburgand and Teva’s CEO Erez Vigodman, are pushing Mylan to take Teva’s $40 billion take-over bid offer seriously.